Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, is scheduled to present at the following investor conferences: 10 th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24 at 1:40 p.m. ET
February 17, 2021
· 1 min read